Fig. 1From: Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyOverall survival in the NT+S and NT−S cohorts. NT+S neoadjuvant treatment plus surgery, NT−S neoadjuvant treatment without surgeryBack to article page